The astrocytic ("peripheral-type") benzodiazepine receptor: role in the pathogenesis of portal-systemic encephalopathy.
An increasing body of evidence supports the notion that activation of astrocytic (peripheral-type) benzodiazepine receptors contributes to the pathogenesis of the central nervous system symptoms which are characteristic of portal-systemic encephalopathy (PSE). Binding site densities for the PTBR ligand [3H-PK11195] are increased in autopsied brain tissue from PSE patients as well as in the brains of animals with experimental chronic liver failure. In the case of the animal studies, increased PTBR sites resulted from increased PTBR gene expression. Exposure of cultured astrocytes to ammonia or manganese (two neurotoxic agents which under normal circumstances are removed by the hepatobiliary system and which are found to accumulate in brain in PSE) results in increased densities of [3H-PK11195] binding sites. Activation of PTBR is known to result in increased cholesterol uptake and increased synthesis in brain of neurosteroids some of which have potent positive allosteric modulator properties on the GABA-A receptor system. Accumulation of such substances in the brain in chronic liver failure could explain the neural inhibition characteristics of PSE.
Butterworth
R F
RF
University of Montreal, Neuroscience Research Unit, Hospital St Luc, Quebec, Canada. butterwr@medelin.umontreal.ca
D000641:Ammonia / Q000378:metabolism; D000818:Animals; D001253:Astrocytes / Q000378:metabolism*; D002908:Chronic Disease; D006501:Hepatic Encephalopathy / Q000209:etiology*; D006801:Humans; D017093:Liver Failure / Q000378:metabolism; D008345:Manganese / Q000378:metabolism; D011963:Receptors, GABA-A / Q000378:metabolism / Q000502:physiology*; D014118:Toxins, Biological / Q000378:metabolism
D011963:Receptors, GABA-A; D014118:Toxins, Biological; D008345:Manganese; D000641:Ammonia